Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Medicinal Products with the Active Ingredient Octreotide (Atc: H01cb02 - no Sustained-Release Dosage Forms)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Interferon Beta 1B, Atc Code: L03ab08 for the Period from May 1St, 2023 to April 30Th, 2025

Open House Drug Rebate Contracts Somatropin, Atc H01ac01

Medicinal Products with the Active Ingredient Octreotide (Atc: H01cb02 - Prolonged-Release Dosage Forms)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Tezepelumab, Atc Code: R03dx11 for the Period from May 1St, 2023 to April 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Amifampridine, Atc Code: N07xx05 for the Period from May 1St, 2023 to April 30Th, 2025

Degree Non-Excl. am Discount Agreements According to Section 130A Paragraph 8 Sgb V Iwe So-Called Open-House Model for the Ws Ibuprofen (Atc Code According to Who: M01ae01), Film-Coated Tablets/Retard Tablets

Open House Original Discount Contracts 2023-11 - Glycopyrronium Bromide (Dosage Form: Hard Capsules with Powder for Inhalation)

Medicines with the Active Substance Combination Formoterol and Aclidinium Bromide (Atc: R03al05)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Natalizumab, Atc Code: L04aa23 for the Period from May 1St, 2023 to April 30Th, 2025